|Articles|April 5, 2017
Schulman IRB Partners with iMedRIS to Develop IBC Technology
Schulman IRB announced that research compliance and administration software provider iMedRIS Data is developing the technology to power Schulman’s forthcoming institutional biosafety committee (IBC) service.
Advertisement
Schulman IRB announced that research compliance and administration software provider iMedRIS Data is developing the technology to power Schulman’s forthcoming institutional biosafety committee (IBC) service.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials
2
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
3
Accelerating Development Through Parallel Execution and Rigorous Quality Controls
4
ACT Brief Weekly Recap: AI Innovation, Industry Resilience, and Supply Chain Readiness
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
